LNP 509

Drug Profile

LNP 509

Latest Information Update: 29 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ADIR; IRIS; Universite Louis Pasteur de Strasbourg
  • Class Cyclopropanes; Pyrroles; Small molecules
  • Mechanism of Action Imidazoline I1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypertension

Most Recent Events

  • 29 Aug 2006 Discontinued - Preclinical for Hypertension in France (unspecified route)
  • 05 Dec 2003 No development reported - Preclinical for Hypertension in France (unspecified route)
  • 06 Jun 2001 Preclinical development for Hypertension in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top